Osteoblast-targeted suppression of PPARγ increases osteogenesis through activation of mTOR signaling.
about
Wnts' fashion statement: from body stature to dysplasia.Betulinic acid is a PPARγ antagonist that improves glucose uptake, promotes osteogenesis and inhibits adipogenesis.Impact of targeted PPARγ disruption on bone remodeling.Regulation of bone formation by baicalein via the mTORC1 pathway.Skeletal integration of energy homeostasis: Translational implications.Metformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms.FOXP1 controls mesenchymal stem cell commitment and senescence during skeletal aging.GATA2 regulates differentiation of bone marrow-derived mesenchymal stem cells.Effects of pulsed electromagnetic fields on postmenopausal osteoporosis.Implications of the Interaction Between miRNAs and Autophagy in Osteoporosis.IGF-1 regulation of key signaling pathways in bone.Rapamycin promotes osteogenesis under inflammatory conditions.Mammalian target of rapamycin as a therapeutic target in osteoporosis.Suppression of mTOR signaling pathway promotes bone marrow mesenchymal stem cells differentiation into osteoblast in degenerative scoliosis: in vivo and in vitro.Effects of the 1, 4-dihydropyridine L-type calcium channel blocker benidipine on bone marrow stromal cells.Secretome analysis of rat osteoblasts during icariin treatment induced osteogenesis.Effects of Melatonin and Its Underlying Mechanism on Ethanol-Stimulated Senescence and Osteoclastic Differentiation in Human Periodontal Ligament Cells and Cementoblasts.Rapamycin rescues BMP mediated midline craniosynostosis phenotype through reduction of mTOR signaling in a mouse modelNUMB maintains bone mass by promoting degradation of PTEN and GLI1 via ubiquitination in osteoblasts
P2860
Q33833409-9C5CAE51-EDD9-4F37-8AD6-088ED7AC5E13Q33916179-DD6EEDC0-BE99-4AA2-A277-C33ECBD26E98Q35648762-2C8E13FA-1319-4AB1-BD92-39DD65B76383Q36067421-7DBA1080-4126-423A-9894-BA8E17E4DB0AQ36662992-8ADE29EE-DB03-4E8F-BF5C-203F31F8905BQ37582441-ABEB4E68-CD2C-4E0F-BADC-19A4CC9B1E55Q37730642-145F6C80-3654-4B2D-9496-DC482A7DACF1Q38473613-0C4E0ADF-56B4-43D5-8C49-C5532F63D619Q38664528-D1D2F9CF-28E3-4A48-A205-8BB255C2A182Q38753100-91A8DECF-A5E5-49F2-A909-8DE2EF36F3A4Q42920696-C0405EA2-F73B-4363-9B21-287A776EED91Q47909330-6E0AA98C-7715-46B3-81F7-315B9583C113Q48187280-D006F1EC-1CFE-4FFB-BBC9-BF7C8469A201Q51303117-9CA617A4-FD6A-4A70-9F25-FE7C16231F8BQ53593434-CC9ACE62-4C00-401E-8E02-DAFCE80EF6B0Q54958160-A8767B3B-99C7-4C16-A160-FD758D81CB8BQ55717578-3481E5EE-CAC0-4509-AE97-72D44A5CFA55Q56262145-1236231D-D1AC-4832-8E74-F0C6B635F0ADQ59130214-8C20A5FA-A58C-4B16-9D4D-47AC3C2BD0C9
P2860
Osteoblast-targeted suppression of PPARγ increases osteogenesis through activation of mTOR signaling.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Osteoblast-targeted suppressio ...... activation of mTOR signaling.
@en
Osteoblast-targeted suppressio ...... activation of mTOR signaling.
@nl
type
label
Osteoblast-targeted suppressio ...... activation of mTOR signaling.
@en
Osteoblast-targeted suppressio ...... activation of mTOR signaling.
@nl
prefLabel
Osteoblast-targeted suppressio ...... activation of mTOR signaling.
@en
Osteoblast-targeted suppressio ...... activation of mTOR signaling.
@nl
P2093
P2860
P356
P1433
P1476
Osteoblast-targeted suppressio ...... h activation of mTOR signaling
@en
P2093
Hongli Sun
Jin Koo Kim
Lorraine P Mutyaba
Paul H Krebsbach
Richard Mortensen
P2860
P304
P356
10.1002/STEM.1455
P577
2013-10-01T00:00:00Z